Pantothenate utilization by plasmodium as a target for antimalarial chemotherapy

Infectious Disorders - Drug Targets

Volumn 10, Issue 3, 2010, Pages 200-216

  Spry, C ^a   van Schalkwyk, D A ^a   Strauss, E ^c   Saliba, K J ^a,b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Biosynthesis; Coenzyme A; Drug target; Malaria; Metabolism; Pantothenate; Plasmodium; Vitamin

Indexed keywords

ANTIMALARIAL AGENT; COENZYME A; PANTOTHENIC ACID;

ARTICLE; BIOSYNTHESIS; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; ERYTHROCYTE; MALARIA; METABOLISM; NONHUMAN; NUTRIENT; PLASMODIUM FALCIPARUM;

EID: 77953739933     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152610791163390     Document Type: Article

References (141)

1. World Health Organization. World malaria report 2008; Geneva, 2008.
2. Singh, B.; Kim Sung, L.; Matusop, A.; Radhakrishnan, A.; Shamsul, S.S.; Cox-Singh, J.; Thomas, A.; Conway, D.J. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet, 2004, 363(9414), 1017-1024.
3. Abdulla, S.; Oberholzer, R.; Juma, O.; Kubhoja, S.; Machera, F.; Membi, C.; Omari, S.; Urassa, A.; Mshinda, H.; Jumanne, A.; Salim, N.; Shomari, M.; Aebi, T.; Schellenberg, D.M.; Carter, T.; Villafana, T.; Demoitie, M.A.; Dubois, M.C.; Leach, A.; Lievens, M.; Vekemans, J.; Cohen, J.; Ballou, W.R.; Tanner, M. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N. Engl. J. Med., 2008, 359(24), 2533-2544.
4. Bejon, P.; Lusingu, J.; Olotu, A.; Leach, A.; Lievens, M.; Vekemans, J.; Mshamu, S.; Lang, T.; Gould, J.; Dubois, M.C.; Demoitie, M.A.; Stallaert, J.F.; Vansadia, P.; Carter, T.; Njuguna, P.; Awuondo, K.O.; Malabeja, A.; Abdul, O.; Gesase, S.; Mturi, N.; Drakeley, C.J.; Savarese, B.; Villafana, T.; Ballou, W.R.; Cohen, J.; Riley, E.M.; Lemnge, M.M.; Marsh, K.; von Seidlein, L. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med., 2008, 359(24), 2521-2532.
5. Guinovart, C.; Aponte, J.J.; Sacarlal, J.; Aide, P.; Leach, A.; Bassat, Q.; Macete, E.; Dobano, C.; Lievens, M.; Loucq, C.; Ballou, W.R.; Cohen, J.; Alonso, P.L. Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One, 2009, 4(4), e5165.
6. Kester, K.E.; Cummings, J.F.; Ofori-Anyinam, O.; Ockenhouse, C.F.; Krzych, U.; Moris, P.; Schwenk, R.; Nielsen, R.A.; Debebe, Z.; Pinelis, E.; Juompan, L.; Williams, J.; Dowler, M.; Stewart, V.A.; Wirtz, R.A.; Dubois, M.C.; Lievens, M.; Cohen, J.; Ballou, W.R.; Heppner, D.G., Jr. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis., 2009, 200(3), 337-346.
7. Lusingu, J.P.; Gesase, S.; Msham, S.; Francis, F.; Lemnge, M.; Seth, M.; Sembuche, S.; Rutta, A.; Minja, D.; Segeja, M.D.; Bosomprah, S.; Cousens, S.; Noor, R.; Chilengi, R.; Druilhe, P. Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. Malar. J., 2009, 8(1), 163.
8. Sacarlal, J.; Aide, P.; Aponte, J.J.; Renom, M.; Leach, A.; Mandomando, I.; Lievens, M.; Bassat, Q.; Lafuente, S.; Macete, E.; Vekemans, J.; Guinovart, C.; Sigauque, B.; Sillman, M.; Milman, J.; Dubois, M.C.; Demoitie, M.A.; Thonnard, J.; Menendez, C.; Ballou, W.R.; Cohen, J.; Alonso, P.L. Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J. Infect. Dis., 2009, 200(3), 329-336.
9. Vanbuskirk, K.M.; O'Neill, M.T.; De La Vega, P.; Maier, A.G.; Krzych, U.; Williams, J.; Dowler, M.G.; Sacci, J.B., Jr.; Kangwanrangsan, N.; Tsuboi, T.; Kneteman, N.M.; Heppner, D.G., Jr.; Murdock, B.A.; Mikolajczak, S.A.; Aly, A.S.; Cowman, A.F.; Kappe, S.H. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc. Natl. Acad. Sci. USA, 2009, 106(31), 13004-13009.
10. Jambou, R.; Legrand, E.; Niang, M.; Khim, N.; Lim, P.; Volney, B.; Ekala, M.T.; Bouchier, C.; Esterre, P.; Fandeur, T.; Mercereau-Puijalon, O. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet, 2005, 366(9501), 1960-1963.
11. Noedl, H.; Se, Y.; Schaecher, K.; Smith, B.L.; Socheat, D.; Fukuda, M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med., 2008, 359(24), 2619-2620.
12. Desjardins, R.E.; Canfield, C.J.; Haynes, J.D.; Chulay, J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother., 1979, 16(6), 710-718.
13. Smilkstein, M.; Sriwilaijaroen, N.; Kelly, J.X.; Wilairat, P.; Riscoe, M. Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening. Antimicrob. Agents Chemother., 2004, 48(5), 1803-1806.
14. Gardner, M.J.; Hall, N.; Fung, E.; White, O.; Berriman, M.; Hyman, R.W.; Carlton, J.M.; Pain, A.; Nelson, K.E.; Bowman, S.; Paulsen, I.T.; James, K.; Eisen, J.A.; Rutherford, K.; Salzberg, S.L.; Craig, A.; Kyes, S.; Chan, M.S.; Nene, V.; Shallom, S.J.; Suh, B.; Peterson, J.; Angiuoli, S.; Pertea, M.; Allen, J.; Selengut, J.; Haft, D.; Mather, M.W.; Vaidya, A.B.; Martin, D.M.; Fairlamb, A.H.; Fraunholz, M.J.; Roos, D.S.; Ralph, S.A.; McFadden, G.I.; Cummings, L.M.; Subramanian, G.M.; Mungall, C.; Venter, J.C.; Carucci, D.J.; Hoffman, S.L.; Newbold, C.; Davis, R.W.; Fraser, C.M.; Barrell, B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature, 2002, 419(6906), 498-511.
15. Choi, S.R.; Mukherjee, P.; Avery, M.A. The fight against drugresistant malaria: novel plasmodial targets and antimalarial drugs. Curr. Med. Chem., 2008, 15(2), 161-171.
16. Trager, W. Further studies on the survival and development in vitro of a malarial parasite. J. Exp. Med., 1943, 77(5), 411-420.
17. Brackett, S.; Waletzky, E.; Baker, M. The relation between panthothenic acid and Plasmodium gallinaceum infections in the chicken and the antimalarial activity of analogues of pantothenic acid. J. Parasitol., 1946, 32(5), 453-462.
18. Divo, A.A.; Geary, T.G.; Davis, N.L.; Jensen, J.B. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J. Protozool., 1985, 32(1), 59-64.
19. Saliba, K.J.; Ferru, I.; Kirk, K. Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite. Antimicrob. Agents Chemother., 2005, 49(2), 632-637.
20. Wrenger, C.; Eschbach, M.L.; Muller, I.B.; Laun, N.P.; Begley, T.P.; Walter, R.D. Vitamin B1 de novo synthesis in the human malaria parasite Plasmodium falciparum depends on external provision of 4-amino-5-hydroxymethyl-2-methylpyrimidine. Biol. Chem., 2006, 387(1), 41-51.
21. Muller, S.; Kappes, B. Vitamin and cofactor biosynthesis pathways in Plasmodium and other apicomplexan parasites. Trends Parasitol., 2007, 23(3), 112-121.
22. Saliba, K.J.; Horner, H.A.; Kirk, K. Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. J. Biol. Chem., 1998, 273(17), 10190-10195.
23. Saliba, K.J.; Kirk, K. H+-coupled pantothenate transport in the intracellular malaria parasite. J. Biol. Chem., 2001, 276(21), 18115-18121.
24. Spry, C.; Saliba, K.J. The human malaria parasite Plasmodium falciparum is not dependent on host coenzyme A biosynthesis. J. Biol. Chem., 2009, 284(37), 24904-24913.
25. Cabantchik, Z.I. Properties of permeation pathways induced in the human red cell membrane by malaria parasites. Blood Cells, 1990, 16(2-3), 421-432.
26. Ginsburg, H. Transport pathways in the malaria-infected erythrocyte: characterization and their use as potential targets for chemotherapy. Biochem. Pharmacol., 1994, 48(10), 1847-1856.
27. Ginsburg, H.; Krugliak, M.; Eidelman, O.; Cabantchik, Z.I. New permeability pathways induced in membranes of Plasmodium falciparum infected erythrocytes. Mol. Biochem. Parasitol., 1983, 8(2), 177-190.
28. Ginsburg, H.; Kutner, S.; Krugliak, M.; Cabantchik, Z.I. Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells. Mol. Biochem. Parasitol., 1985, 14(3), 313-322.
29. Kirk, K.; Horner, H.A.; Elford, B.C.; Ellory, J.C.; Newbold, C.I. Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J. Biol. Chem., 1994, 269(5), 3339-3347.
30. Desai, S.A.; Krogstad, D.J.; McCleskey, E.W. A nutrientpermeable channel on the intraerythrocytic malaria parasite. Nature, 1993, 362(6421), 643-646.
31. Lehane, A.M.; Marchetti, R.V.; Spry, C.; van Schalkwyk, D.A.; Teng, R.; Kirk, K.; Saliba, K.J. Feedback inhibition of pantothenate kinase regulates pantothenol uptake by the malaria parasite. J. Biol. Chem., 2007, 282(35), 25395-25405.
32. Trager, W. Studies on the extracellular cultivation of an intracellular parasite (avian malaria). II. The effects of malate and of coenzyme A concentrates. J. Exp. Med., 1952, 96(5), 465-476.
33. Trager, W. Coenzyme A and the malaria parasite Plasmodium lophurae. J. Protozool., 1954, 1(4), 231-237.
34. Bennett, T.P.; Trager, W. Pantothenic acid metabolism during avian malaria infection: pantothenate kinase activity in duck erythrocytes and in Plasmodium lophurae. J. Protozool., 1967, 14(2), 214-216.
35. Brohn, F.H.; Trager, W. Coenzyme A requirement of malaria parasites: enzymes of coenzyme A biosynthesis in normal duck erythrocytes and erythrocytes infected with Plasmodium lophurae. Proc. Natl. Acad. Sci. U. S. A., 1975, 72(6), 2456-2458.
36. Begley, T.P.; Kinsland, C.; Strauss, E. The biosynthesis of coenzyme A in bacteria. Vitam. Horm., 2001, 61, 157-171.
37. Mercer, A.C.; Burkart, M.D. The ubiquitous carrier protein--a window to metabolite biosynthesis. Nat. Prod. Rep., 2007, 24(4), 750-773.
38. Ralph, S.A.; van Dooren, G.G.; Waller, R.F.; Crawford, M.J.; Fraunholz, M.J.; Foth, B.J.; Tonkin, C.J.; Roos, D.S.; McFadden, G.I. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol., 2004, 2(3), 203-216.
39. Lack, G.; Homberger-Zizzari, E.; Folkers, G.; Scapozza, L.; Perozzo, R. Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates. J. Biol. Chem., 2006, 281(14), 9538-9546.
40. Pillai, S.; Rajagopal, C.; Kapoor, M.; Kumar, G.; Gupta, A.; Surolia, N. Functional characterization of beta-ketoacyl-ACP reductase (FabG) from Plasmodium falciparum. Biochem. Biophys. Res. Commun., 2003, 303(1), 387-392.
41. Prigge, S.T.; He, X.; Gerena, L.; Waters, N.C.; Reynolds, K.A. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII. Biochemistry, 2003, 42(4), 1160-1169.
42. Sharma, S.K.; Kapoor, M.; Ramya, T.N.; Kumar, S.; Kumar, G.; Modak, R.; Sharma, S.; Surolia, N.; Surolia, A. Identification, characterization, and inhibition of Plasmodium falciparum betahydroxyacyl-acyl carrier protein dehydratase (FabZ). J. Biol. Chem., 2003, 278(46), 45661-45671.
43. Surolia, N.; Surolia, A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med., 2001, 7(2), 167-173.
44. Waters, N.C.; Kopydlowski, K.M.; Guszczynski, T.; Wei, L.; Sellers, P.; Ferlan, J.T.; Lee, P.J.; Li, Z.; Woodard, C.L.; Shallom, S.; Gardner, M.J.; Prigge, S.T. Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum. Mol. Biochem. Parasitol., 2002, 123(2), 85-94.
45. Gilson, P.R.; Nebl, T.; Vukcevic, D.; Moritz, R.L.; Sargeant, T.; Speed, T.P.; Schofield, L.; Crabb, B.S. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteomics, 2006, 5(7), 1286-1299.
46. Palacpac, N.M.; Hiramine, Y.; Mi-ichi, F.; Torii, M.; Kita, K.; Hiramatsu, R.; Horii, T.; Mitamura, T. Developmental-stagespecific triacylglycerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium falciparum-infected erythrocytes. J. Cell Sci., 2004, 117(pt. 8), 1469-1480.
47. Vial, H.J.; Thuet, M.J.; Philippot, J.R. Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures. J. Protozool., 1982, 29(2), 258-263.
48. Vaughan, A.M.; O'Neill, M.T.; Tarun, A.S.; Camargo, N.; Phuong, T.M.; Aly, A.S.; Cowman, A.F.; Kappe, S.H. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol., 2009, 11(3), 506-520.
49. Yu, M.; Kumar, T.R.; Nkrumah, L.J.; Coppi, A.; Retzlaff, S.; Li, C.D.; Kelly, B.J.; Moura, P.A.; Lakshmanan, V.; Freundlich, J.S.; Valderramos, J.C.; Vilcheze, C.; Siedner, M.; Tsai, J.H.; Falkard, B.; Sidhu, A.B.; Purcell, L.A.; Gratraud, P.; Kremer, L.; Waters, A.P.; Schiehser, G.; Jacobus, D.P.; Janse, C.J.; Ager, A.; Jacobs, W.R., Jr.; Sacchettini, J.C.; Heussler, V.; Sinnis, P.; Fidock, D.A. The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. Cell Host Microbe, 2008, 4(6), 567-578.
50. Watkins, P.A. Fatty acid activation. Prog. Lipid Res., 1997, 36(1), 55-83.
51. Bethke, L.L.; Zilversmit, M.; Nielsen, K.; Daily, J.; Volkman, S.K.; Ndiaye, D.; Lozovsky, E.R.; Hartl, D.L.; Wirth, D.F. Duplication, gene conversion, and genetic diversity in the species-specific acyl-CoA synthetase gene family of Plasmodium falciparum. Mol. Biochem. Parasitol., 2006, 150(1), 10-24.
52. Matesanz, F.; Duran-Chica, I.; Alcina, A. The cloning and expression of Pfacs1, a Plasmodium falciparum fatty acyl coenzyme A synthetase-1 targeted to the host erythrocyte cytoplasm. J. Mol. Biol., 1999, 291(1), 59-70.
53. Matesanz, F.; Tellez, M.M.; Alcina, A. The Plasmodium falciparum fatty acyl-CoA synthetase family (PfACS) and differential stage-specific expression in infected erythrocytes. Mol. Biochem. Parasitol., 2003, 126(1), 109-112.
54. Beaumelle, B.D.; Vial, H.J. Acyl-CoA synthetase activity in Plasmodium knowlesi-infected erythrocytes displays peculiar substrate specificities. Biochim. Biophys. Acta, 1988, 958(1), 1-9.
55. Mi-Ichi, F.; Kita, K.; Mitamura, T. Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth. Parasitology, 2006, 133(pt. 4), 399-410.
56. Malhotra, K.T.; Malhotra, K.; Lubin, B.H.; Kuypers, F.A. Identification and molecular characterization of acyl-CoA synthetase in human erythrocytes and erythroid precursors. Biochem. J., 1999, 344(pt.1), 135-143.
57. Davidson, B.C.; Cantrill, R.C. Erythrocyte membrane acyl:CoA synthetase activity. FEBS Lett., 1985, 193(1), 69-74.
58. Bozdech, Z.; Llinas, M.; Pulliam, B.L.; Wong, E.D.; Zhu, J.; DeRisi, J.L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol., 2003, 1(1), E5.
59. Olszewski, K.L.; Morrisey, J.M.; Wilinski, D.; Burns, J.M.; Vaidya, A.B.; Rabinowitz, J.D.; Llinas, M. Host-parasite interactions revealed by Plasmodium falciparum metabolomics. Cell Host Microbe, 2009, 5(2), 191-199.
60. Bryant, C.; Voller, A.; Smith, M.J. The incorporation of radioactivity from [14C]glucose into the soluble metabolic intermediates of malaria parasites. Am. J. Trop. Med. Hyg., 1964, 13(4), 515-519.
61. Scheibel, L.W.; Pflaum, W.K. Carbohydrate metabolism in Plasmodium knowlesi. Comp. Biochem. Physiol., 1970, 37(4), 543-553.
62. Foth, B.J.; Stimmler, L.M.; Handman, E.; Crabb, B.S.; Hodder, A.N.; McFadden, G.I. The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast. Mol. Microbiol., 2005, 55(1), 39-53.
63. van Dooren, G.G.; Stimmler, L.M.; McFadden, G.I. Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol. Rev., 2006, 30(4), 596-630.
64. Teng, R.; Junankar, P.R.; Bubb, W.A.; Rae, C.; Mercier, P.; Kirk, K. Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by 1H NMR spectroscopy. NMR Biomed., 2009, 22(3), 292-302.
65. Trager, W.; Brohn, F.H. Coezyme A requirement of malaria parasites: effects of coenzyme A precursors on extracellular development in vitro of Plasmodium lophurae. Proc. Natl. Acad. Sci. USA, 1975, 72(5), 1834-1837.
66. Trager, W. Loose ends: axenic culture, parasitophorous vacuoles, bird malaria. Parassitologia, 2002, 44(1-2), 117-121.
67. Trager, W.; Williams, J. Extracellular (axenic) development in vitro of the erythrocytic cycle of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 1992, 89(12), 5351-5355.
68. Trager, W.; Zung, J.; Tershakovec, M. Initial extracellular development in vitro of erythrocytic stages of malaria parasites (Plasmodium falciparum). Proc. Natl. Acad. Sci. USA, 1990, 87(15), 5618-5622.
69. George, N.; Pick, H.; Vogel, H.; Johnsson, N.; Johnsson, K. Specific labeling of cell surface proteins with chemically diverse compounds. J. Am. Chem. Soc., 2004, 126(29), 8896-8897.
70. La Clair, J.J.; Foley, T.L.; Schegg, T.R.; Regan, C.M.; Burkart, M.D. Manipulation of carrier proteins in antibiotic biosynthesis. Chem. Biol., 2004, 11(2), 195-201.
71. Mercer, A.C.; La Clair, J.J.; Burkart, M.D. Fluorescent multiplex analysis of carrier protein post-translational modification. ChemBioChem, 2005, 6(8), 1335-1337.
72. van Wyk, M.; Strauss, E. One-pot preparation of coenzyme A analogues via an improved chemo-enzymatic synthesis of pre-CoA thioester synthons. Chem. Commun. (Camb.), 2007, (4), 398-400.
73. Worthington, A.S.; Burkart, M.D. One-pot chemo-enzymatic synthesis of reporter-modified proteins. Org. Biomol. Chem., 2006, 4(1), 44-46.
74. Yin, J.; Liu, F.; Li, X.H.; Walsh, C.T. Labeling proteins with small molecules by site-specific posttranslational modification. J. Am. Chem. Soc., 2004, 126(25), 7754-7755.
75. Wittwer, C.T.; Schweitzer, C.; Pearson, J.; Song, W.O.; Windham, C.T.; Wyse, B.W.; Hansen, R.G. Enzymes for liberation of pantothenic acid in blood: use of plasma pantetheinase. Am. J. Clin. Nutr., 1989, 50(5), 1072-1078.
76. Berliner, R.W.; Blanchard, K.C.; Butler, T.C.; Clark, W.M.; Marshall, E.K.; Schmidt, L.H.; Shannon, J.A. A survey of antimalarial drugs 1941-1945; Wiselogle, F.Y., Ed.; J. W. Edwards: Michigan, 1946.
77. Blanchard, K.C.; Schmid, L.H. Chemical series of potential interest. In: A survey of antimalarial drugs 1941-1945; Wiselogle, F.Y., Ed.; J. W. Edwards: Michigan, 1946; pp. 73-175.
78. Cantrell, W. Antagonism of calcium pantothenate for the antimalarial effect of pantoyltaurylamide. J. Parasitol., 1949, 35(2), 219-220.
79. Saliba, K.J.; Kirk, K. CJ-15,801, a fungal natural product, inhibits the intraerythrocytic stage of Plasmodium falciparum in vitro via an effect on pantothenic acid utilisation. Mol. Biochem. Parasitol., 2005, 141(1), 129-131.
80. Senear, A.E.; Rapport, M.M.; Koepfli, J.B. The synthesis of potential antimalarials - derivatives of α,γ-dihydroxy-β,β-dimethyl-N-ethylbutyramide. J. Biol. Chem., 1947, 167(1), 229-234.
81. Spry, C.; Chai, C.L.; Kirk, K.; Saliba, K.J. A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Antimicrob. Agents Chemother., 2005, 49(11), 4649-4657.
82. Trager, W. Coenzyme A and the antimalarial action in vitro of antipantothenate against Plasmodium lophurae, P. coatneyi and P. falciparum. Trans. N Y Acad. Sci., 1966, 28(8), 1094-1108.
83. Winterbottom, R.; Clapp, J.W.; Miller, W.H.; English, J.P.; Roblin, R.O. Studies in chemotherapy. XV. Amides of pantoyltaurine. J. Am. Chem. Soc., 1947, 69(6), 1393-1401.
84. Woolley, D.W.; Collyer, M.L. Phenyl pantothenone, an antagonist of pantothenic acid. J. Biol. Chem., 1945, 159(2), 263-271.
85. Singher, H.O.; Millman, N.; Bosworth, M.R. Toxicity and pharmacology of SN-13592 - an analogue of phenyl pantothenone. Proc. Soc. Exp. Biol. Med., 1948, 67(3), 388-390.
86. Spry, C.; Kirk, K.; Saliba, K.J. Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol. Rev., 2008, 32(1), 56-106.
87. Sugie, Y.; Dekker, K.A.; Hirai, H.; Ichiba, T.; Ishiguro, M.; Shiomi, Y.; Sugiura, A.; Brennan, L.; Duignan, J.; Huang, L.H.; Sutcliffe, J.; Kojima, Y. CJ-15,801, a novel antibiotic from a fungus, Seimatosporium sp. J. Antibiot. (Tokyo), 2001, 54(12), 1060-1065.
88. Staines, H.M.; Ellory, J.C.; Chibale, K. The new permeability pathways: targets and selective routes for the development of new antimalarial agents. Comb. Chem. High Throughput Screen., 2005, 8(1), 81-88.
89. Kirk, K.; Horner, H.A. In search of a selective inhibitor of the induced transport of small solutes in Plasmodium falciparuminfected erythrocytes: effects of arylaminobenzoates. Biochem. J., 1995, 311(pt. 3), 761-768.
90. Staines, H.M.; Dee, B.C.; O'Brien, M.; Lang, H.J.; Englert, H.; Horner, H.A.; Ellory, J.C.; Kirk, K. Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes. Mol. Biochem. Parasitol., 2004, 133(2), 315-318.
91. Staines, H.M.; Alkhalil, A.; Allen, R.J.; De Jonge, H.R.; Derbyshire, E.; Egee, S.; Ginsburg, H.; Hill, D.A.; Huber, S.M.; Kirk, K.; Lang, F.; Lisk, G.; Oteng, E.; Pillai, A.D.; Rayavara, K.; Rouhani, S.; Saliba, K.J.; Shen, C.; Solomon, T.; Thomas, S.L.; Verloo, P.; Desai, S.A. Electrophysiological studies of malaria parasite-infected erythrocytes: current status. Int. J. Parasitol., 2007, 37(5), 475-482.
92. Martial, S.; Olives, B.; Abrami, L.; Couriaud, C.; Bailly, P.; You, G.; Hediger, M.A.; Cartron, J.P.; Ripoche, P.; Rousselet, G. Functional differentiation of the human red blood cell and kidney urea transporters. Am. J. Physiol. Renal. Physiol., 1996, 271(6 pt. 2), F1264-1268.
93. Muller, F.; Huber, K.; Pfannkuche, H.; Aschenbach, J.R.; Breves, G.; Gabel, G. Transport of ketone bodies and lactate in the sheep ruminal epithelium by monocarboxylate transporter 1. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 283(5), G1139-1146.
94. Nelson, J.A.; Falk, R.E. Phloridzin and phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in vitro and in vivo. Anticancer Res., 1993, 13(6A), 2293-2299.
95. Watt, P.W.; MacLennan, P.A.; Hundal, H.S.; Kuret, C.M.; Rennie, M.J. L(+)-lactate transport in perfused rat skeletal muscle: kinetic characteristics and sensitivity to pH and transport inhibitors. Biochim. Biophys. Acta, 1988, 944(2), 213-222.
96. Desai, S.A.; Bezrukov, S.M.; Zimmerberg, J. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature, 2000, 406(6799), 1001-1005.
97. Kirk, K.; Saliba, K.J. Targeting nutrient uptake mechanisms in Plasmodium. Curr. Drug Targets, 2007, 8(1), 75-88.
98. Martin, R.E.; Henry, R.I.; Abbey, J.L.; Clements, J.D.; Kirk, K. The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol., 2005, 6(3), R26.
99. Staines, H.M.; Ellory, J.C.; Kirk, K. Perturbation of the pump-leak balance for Na+ and K+ in malaria-infected erythrocytes. Am. J. Physiol. Cell Physiol., 2001, 280(6), C1576-1587.
100. Fisher, M.N.; Robishaw, J.D.; Neely, J.R. The properties and regulation of pantothenate kinase from rat heart. J. Biol. Chem., 1985, 260(29), 15745-15751.
101. Halvorsen, O.; Skrede, S. Regulation of the biosynthesis of CoA at the level of pantothenate kinase. Eur. J. Biochem., 1982, 124(1), 211-215.
102. Zhang, Y.M.; Rock, C.O.; Jackowski, S. Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters. J. Biol. Chem., 2005, 280(38), 32594-32601.
103. Zhang, Y.M.; Rock, C.O.; Jackowski, S. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration. J. Biol. Chem., 2006, 281(1), 107-114.
104. Leonardi, R.; Chohnan, S.; Zhang, Y.M.; Virga, K.G.; Lee, R.E.; Rock, C.O.; Jackowski, S. A pantothenate kinase from Staphylococcus aureus refractory to feedback regulation by coenzyme A. J. Biol. Chem., 2005, 280(5), 3314-3322.
105. Strauss, E.; Begley, T.P. The antibiotic activity of Npentylpantothenamide results from its conversion to ethyldethiacoenzyme A, a coenzyme A antimetabolite. J. Biol. Chem., 2002, 277(50), 48205-48209.
106. Zhang, Y.M.; Frank, M.W.; Virga, K.G.; Lee, R.E.; Rock, C.O.; Jackowski, S. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites. J. Biol. Chem., 2004, 279(49), 50969-50975.
107. Kumar, P.; Chhibber, M.; Surolia, A. How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun., 2007, 361(4), 903-909.
108. Genschel, U. Coenzyme A biosynthesis: reconstruction of the pathway in archaea and an evolutionary scenario based on comparative genomics. Mol. Biol. Evol., 2004, 21(7), 1242-1251.
109. Hong, B.S.; Yun, M.K.; Zhang, Y.M.; Chohnan, S.; Rock, C.O.; White, S.W.; Jackowski, S.; Park, H.W.; Leonardi, R. Prokaryotic type II and type III pantothenate kinases: The same monomer fold creates dimers with distinct catalytic properties. Structure, 2006, 14(8), 1251-1261.
110. Yang, K.; Eyobo, Y.; Brand, L.A.; Martynowski, D.; Tomchick, D.; Strauss, E.; Zhang, H. Crystal structure of a type III pantothenate kinase: Insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria. J. Bacteriol., 2006, 188(15), 5532-5540.
111. Hong, B.S.; Senisterra, G.; Rabeh, W.M.; Vedadi, M.; Leonardi, R.; Zhang, Y.M.; Rock, C.O.; Jackowski, S.; Park, H.W. Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder. J. Biol. Chem., 2007, 282(38), 27984-27993.
112. Cheek, S.; Ginalski, K.; Zhang, H.; Grishin, N.V. A comprehensive update of the sequence and structure classification of kinases. BMC Struct. Biol., 2005, 5, 6.
113. Cheek, S.; Zhang, H.; Grishin, N.V. Sequence and structure classification of kinases. J. Mol. Biol., 2002, 320(4), 855-881.
114. Pizzi, E.; Frontali, C. Low-complexity regions in Plasmodium falciparum proteins. Genome Res., 2001, 11(2), 218-229.
115. Singh, G.P.; Chandra, B.R.; Bhattacharya, A.; Akhouri, R.R.; Singh, S.K.; Sharma, A. Hyper-expansion of asparagines correlates with an abundance of proteins with prion-like domains in Plasmodium falciparum. Mol. Biochem. Parasitol., 2004, 137(2), 307-319.
116. Zhang, Y.M.; Chohnan, S.; Virga, K.G.; Stevens, R.D.; Ilkayeva, O.R.; Wenner, B.R.; Bain, J.R.; Newgard, C.B.; Lee, R.E.; Rock, C.O.; Jackowski, S. Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. Chem. Biol., 2007, 14(3), 291-302.
117. Mehlin, C.; Boni, E.; Buckner, F.S.; Engel, L.; Feist, T.; Gelb, M.H.; Haji, L.; Kim, D.; Liu, C.; Mueller, N.; Myler, P.J.; Reddy, J.T.; Sampson, J.N.; Subramanian, E.; Van Voorhis, W.C.; Worthey, E.; Zucker, F.; Hol, W.G. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol. Biochem. Parasitol., 2006, 148(2), 144-160.
118. Shen, D.; Huang, Q.; Sha, Y.; Bing, Z. Cloning and confirmation of several potential pantothenate kinases which display different specificities for pantothenate analogues. J. Tsinghua Univ., 2008, 48(3), 403-407.
119. Somogyi, M. Determination of Blood Sugar. J. Biol. Chem., 1945, 160(1), 69-73.
120. Ivey, R.A.; Zhang, Y.M.; Virga, K.G.; Hevener, K.; Lee, R.E.; Rock, C.O.; Jackowski, S.; Park, H.W. The structure of the pantothenate kinase.ADP.pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites. J. Biol. Chem., 2004, 279(34), 35622-35629.
121. van Schalkwyk, D.A.; Priebe, W.; Saliba, K.J. The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum. J. Pharmacol. Exp. Ther., 2008, 327(2), 511-517.
122. Mercer, A.C.; Meier, J.L.; Hur, G.H.; Smith, A.R.; Burkart, M.D. Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli. Bioorg. Med. Chem. Lett., 2008, 18(22), 5991-5994.
123. Rock, C.O.; Calder, R.B.; Karim, M.A.; Jackowski, S. Pantothenate kinase regulation of the intracellular concentration of coenzyme A. J. Biol. Chem., 2000, 275(2), 1377-1383.
124. Pinney, J.W.; Shirley, M.W.; McConkey, G.A.; Westhead, D.R. metaSHARK: software for automated metabolic network prediction from DNA sequence and its application to the genomes of Plasmodium falciparum and Eimeria tenella. Nucleic Acids Res., 2005, 33(4), 1399-1409.
125. Zhao, L.; Allanson, N.M.; Thomson, S.P.; Maclean, J.K.; Barker, J.J.; Primrose, W.U.; Tyler, P.D.; Lewendon, A. Inhibitors of phosphopantetheine adenylyltransferase. Eur. J. Med. Chem., 2003, 38(4), 345-349.
126. Daugherty, M.; Polanuyer, B.; Farrell, M.; Scholle, M.; Lykidis, A.; de Crecy-Lagard, V.; Osterman, A. Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics. J. Biol. Chem., 2002, 277(24), 21431-21439.
127. Geerlof, A.; Lewendon, A.; Shaw, W.V. Purification and characterization of phosphopantetheine adenylyltransferase from Escherichia coli. J. Biol. Chem., 1999, 274(38), 27105-27111.
128. Kupke, T. Molecular characterization of the 4'-phosphopantothenoylcysteine decarboxylase domain of bacterial Dfp flavoproteins. J. Biol. Chem., 2001, 276(29), 27597-27604.
129. Kupke, T. Molecular characterization of the 4'-phosphopantothenoylcysteine synthetase domain of bacterial Dfp flavoproteins. J. Biol. Chem., 2002, 277(39), 36137-36145.
130. Mishra, P.; Park, P.K.; Drueckhammer, D.G. Identification of yacE (coaE) as the structural gene for dephosphocoenzyme A kinase in Escherichia coli K-12. J. Bacteriol., 2001, 183(9), 2774-2778.
131. Birkholtz, L.M.; Blatch, G.; Coetzer, T.L.; Hoppe, H.C.; Human, E.; Morris, E.J.; Ngcete, Z.; Oldfield, L.; Roth, R.; Shonhai, A.; Stephens, L.; Louw, A.I. Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J., 2008, 7, 197.
132. Vedadi, M.; Lew, J.; Artz, J.; Amani, M.; Zhao, Y.; Dong, A.; Wasney, G.A.; Gao, M.; Hills, T.; Brokx, S.; Qiu, W.; Sharma, S.; Diassiti, A.; Alam, Z.; Melone, M.; Mulichak, A.; Wernimont, A.; Bray, J.; Loppnau, P.; Plotnikova, O.; Newberry, K.; Sundararajan, E.; Houston, S.; Walker, J.; Tempel, W.; Bochkarev, A.; Kozieradzki, I.; Edwards, A.; Arrowsmith, C.; Roos, D.; Kain, K.; Hui, R. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol. Biochem. Parasitol., 2007, 151(1), 100-110.
133. Manoj, N.; Strauss, E.; Begley, T.P.; Ealick, S.E. Structure of human phosphopantothenoylcysteine synthetase at 2.3 Å resolution. Structure, 2003, 11(8), 927-936.
134. van Wyk, M.; Strauss, E. Development of a method for the parallel synthesis and purification of N-substituted pantothenamides, known inhibitors of coenzyme A biosynthesis and utilization. Org. Biomol. Chem., 2008, 6(23), 4348-4355.
135. Lutz, R.E.; Wilson, J.W.; Deinet, A.J.; Harnest, G.H.; Martin, T.A.; Freek, J.A. Antimalarials - amides related to phenylpantothenone. J. Org. Chem., 1947, 12(1), 96-107.
136. Mead, J.F.; Koepfli, J.B. The synthesis of potential antimalarials - the preparation of methylated amides of taurine and their pantoyl derivatives. J. Org. Chem., 1947, 12(2), 295-297.
137. Mead, J.F.; Rapport, M.M.; Senear, A.E.; Maynard, J.T.; Koepfli, J.B. The synthesis of potential antimalarials - derivatives of pantoyltaurine. J. Biol. Chem., 1946, 163(2), 465-473.
138. Berliner, R.W.; Butler, T.C. Summary of data on the drugs tested in man. In: A survey of antimalarial drugs 1941-1945; Wiselogle, F.Y., Ed.; J. W. Edwards: Michigan, 1946; pp. 221-451.
139. Trager, W. Further studies on the effects of antipantothenates on malaria parasites (Plasmodium coatneyi and P. falciparum) in vitro. J. Protozool., 1971, 18(2), 232-239.
140. Pei, J.; Kim, B.H.; Grishin, N.V. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res., 2008, 36(7), 2295-2300.
141. Bates, P.A.; Kelley, L.A.; MacCallum, R.M.; Sternberg, M.J. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins, 2001, (Suppl. 5), 39-46.